We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Interim results from a phase 1 trial showed that INO-4800 was safe and well-tolerated and induced immune responses in a majority of participants. Read More
Early trial data from Johnson & Johnson’s COVID-19 vaccine candidate AD26.COV2.S has shown that a single dose was enough to generate a strong antibody response. Read More
Operation Warp Speed, the Trump administration’s COVID-19 vaccine and treatment initiative, is in “full alignment” with the FDA raising the bar on what’s required for an Emergency Use Authorization of a COVID-19 vaccine, the top adviser to the initiative says. That contradicts what President Trump has been saying. Read More
J&J last week began the largest phase 3 trial of a COVID-19 vaccine to date, in which it aims to enroll 60,000 participants across eight countries. Read More
Humanigen has teamed up with Massachusetts-based Thermo Fisher Scientific, which will help manufacture the drug substance for Humanigen’s COVID-19 monoclonal antibody lenzilumab. Read More
The UK is launching the first COVID-19 challenge trials, in which healthy volunteers will be exposed to the virus to assess the safety and effectiveness of vaccine candidates, the government says. Read More
The head of the FDA’s vaccine advisory committee has recused herself from its upcoming COVID-19 vaccine review to avoid any appearance of a conflict of interest stemming from her leadership role in Moderna’s vaccine trial. Read More
In a letter sent yesterday, leaders of the House Energy and Commerce Committee demanded that the HHS Office of Inspector General (OIG) conduct a full investigation into politically motivated interference by the White House in the affairs of the Centers for Disease Control and Prevention (CDC) during the pandemic. Read More
New York Gov. Andrew Cuomo is threatening not to distribute FDA-approved COVID-19 vaccines in his state until they receive approval from a state task force of scientists, doctors and health experts. Read More
Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said Thursday that White House interference with the FDA’s policies for authorizing a COVID-19 vaccine would be “troublesome.” Read More
Novavax yesterday launched a phase 3 clinical trial of its COVID-19 vaccine in the UK, becoming the latest drugmaker to bring a vaccine candidate to late-stage testing. Read More